Previous work has shown that the Simian Virus 40 T antigen (T antigen) cannot transform mouse embryo fibroblasts (MEFs) that do not express the type 1 insulinlike growth factor receptor (IGF-IR). We have now investigated the mechanism(s) by which the transforming activity of T antigen is affected by IGF-IR signaling. We demonstrate that transformation by T antigen of MEFs and several other cell lines requires an insulin receptor substrate-1 (IRS-1) phosphorylated on tyrosines. If IRS-1 is not expressed, or is serine phosphorylated or otherwise inactive, T antigen fails to transform cells in culture. For instance, while T antigen cannot transform 32D myeloid cells (that do not express IRS-1), its transforming activity is restored by the expression of a wild-type IRS-1, but not of an IRS-1 mutated at the PI3K binding sites. The importance of IRS-1 activation of PI3K in T-antigen transformation is supported by the finding that a constitutively activated p110 subunit of PI3K, a target of IRS-1, overcomes the inability of T antigen to transform MEFs with a serine phosphorylated IRS-1. Taken together, these results indicate that the IRS-1/PI3K signaling is one of the mechanisms regulating transformation by the SV40 T antigen. We propose that the requirement for a tyrosylphosphorylated IRS-1 provides a mechanism to explain the failure of T antigen to transform MEFs with deleted IGF-IR genes.
Introduction
The Simian Virus 40 T antigen has been known for many years as an oncogene that can readily transform a variety of cells in culture (Fanning, 1992; Ali and DeCaprio, 2001; Pipas and Levine, 2001) . A role of the type 1 insulin-like growth factor receptor (IGF-IR) in transformation by the SV40 T antigen (heretofore designated as Tag) had been demonstrated by the observations of Sell et al. (1993 Sell et al. ( , 1994 , who used fibroblasts (mouse embryo fibroblasts (MEFs)) generated from mouse embryos with a deletion of the IGF-IR genes . These MEFs, designated as R-cells, could not be transformed by the stable expression of Tag (Sell et al., 1993) , which is known to readily transform MEFs with a normal number of IGF-I receptors. Reintroduction (by stable transfection) of the IGF-IR into Tag-expressing R-cells restored the ability of T antigen to transform (Sell et al., 1993) . R-cells are also refractory to transformation by the JC virus T antigen, which is the human homolog of the SV40 Tag (Del Valle et al., 2002) . A second connection between T-antigen transformation and IGF-IR signaling came from another source. It is generally accepted that the oncogenicity of the SV40 T antigen depends on its ability to bind cellular proteins, among which are prominent p53 and the retinoblastoma proteins (Ali and DeCaprio, 2001; Pipas and Levine, 2001) . Tag interacts also with the insulin receptor substrate-1 (IRS-1) (Zhouli et al., 1995) , a docking protein for both the insulin and the IGF-I receptors (White, 1998) . We suspected that the IRS-1/Tag interaction had a functional significance, because Tag fails to transform 32D murine myeloid cells (Zhou-li et al., 1997) that do not express IRS-1 or IRS-2 (Wang et al., 1993; Valentinis et al., 1999) . However, while it seemed that transformation by Tag could be affected by both the IGF-IR and IRS-1, at least in MEFs and myeloid cells, no mechanistic explanation has been readily available. The purpose of this investigation is to explore the mechanism involved in the failure of Tag to transform IGF-IR-negative cells, taking as a starting clue the IRS-1/Tag interaction.
The interaction between Tag and IRS-1 was originally thought to occur between IRS-1 and that small fraction of Tag that can be found in the cytoplasm (Santos and Butel, 1982) . More recently, IRS-1 has been found in the nuclei of cells expressing the T antigen of either the JC or the SV40 virus Prisco et al., 2002) . In these cells, most of the IRS-1 is in the nuclei, where it colocalizes with Tag, as demonstrated by immunohistochemistry, confocal microscopy and subcellular fractionation (Tu et al., 2002; Sun et al., 2003) . Using MEFs, 32D cells and other cell lines, we have found that in all the cell lines tested, one of the requirements for transformation by Tag is an IRS-1 phosphorylated on tyrosines. If IRS-1 is absent, or serine phosphorylated or otherwise inactive (mutations at the PI3K-binding sites), Tag is incapable of transforming the cell lines used in our experiments. The ability of Tag to transform R-/T cells is restored by the tyrosine phosphorylation of IRS-1 or by a constitutively activated p110 subunit of PI3K, a target of IRS-1 (Myers et al., 1994) . Taken together, these findings are compelling evidence for a novel, critical role of IGF-IR/IRS-1 signaling in transformation by Tag.
Results
Phosphorylation of IRS-1 in R-/T cells R-cells are MEFs generated from mouse embryos with a targeted disruption of the IGF-IR genes . They do not express the IGF-IR protein and do not respond to IGF-1, although they grow in 10% serum (Sell et al., 1993) . R-cells expressing Tag (R-/T cells) do not form foci in monolayers and do not form colonies in soft agar (Sell et al., 1993) , the two accepted criteria for transformation in vitro (Macpherson and Montagnier, 1964) . We investigated the status of IRS-1 in R-/T cells. In Figure 1 (panel a), lysates from R-cells, R-/T cells and R-/v-src cells were immunoprecipitated with an antibody to IRS-1. The blots were developed with an antiphosphotyrosine antibody (PY20). Although IRS-1 translocates to the nuclei of R-/T cells (Tu et al., 2002) , it is not tyrosyl phosphorylated, whether the cells are in serum-free medium (SFM) or in serum. R-/v-src cells were used as a control for the technique, and IRS-1 is tyrosyl phosphorylated in R-/vsrc cells, whether in SFM (À) or in 10% serum ( þ ). The lower row shows that IRS-1 was immunoprecipitated in all cell lines, roughly in similar amounts, except in parental 32D cells (used as controls, because they do not express IRS-1). This experiment has been repeated twice, with the same results.
The status of IRS-1 in BalbA58 cells that are Balb/ c3T3 cells stably expressing a tsA 58 mutant of Tag (Valentinis et al., 1994) is different. BalbA58 cells express a normal number of IGF-IR (22 Â 10 3 receptors/cell), and are transformed at the permissive temperature of 341C. In these cells, IRS-1 is tyrosyl phosphorylated at 341C (Figure 1, panel b) . Panel a in Figure 1 showed some slight changes in IRS-1 mobility suggestive of serine phosphorylation of IRS-1 under certain conditions. We repeated and extended this experiment and the results are shown in Figure 1 , panel c. In R-and R-/T cells there is a definite shift in IRS-1 mobility, which is decreased by treatment with alkaline phosphatase (upper row). Using an antibody to serine 616 of IRS-1 (see Materials and methods), we confirm the serine phosphorylation of IRS-1 in these two cell lines (lower row) under various growth conditions. Both R-and R-/T cells show an IRS-1 that is strongly positive for phosphorylation on serine 616.
T antigen transforms R-derived cells with low numbers of IGF-IR
BalbA58 cells have a normal number of IGF-IRs, which makes them susceptible to transformation by Tag (Valentinis et al., 1994) . We asked whether very low levels of IGF-IR would be sufficient to cause both tyrosyl phosphorylation of IRS-1 and transformation by Tag. We chose cell lines, generated from R-cells, with such low levels of IGF-IR that they fail to respond to IGF-1 with cell proliferation. R12 cells express 7 Â 10 3 receptors/cell, while R508 express 17 Â 10 3 receptors/ cell. These cell lines cannot grow in SFM supplemented solely by IGF-I and do not form colonies in soft agar, although they respond to IGF-I with tyrosyl phosphorylation of IRS-1 (Rubini et al., 1997; Reiss et al., 1998) . If tyrosine phosphorylation of IRS-1 plays an important role in transformation by Tag, then Tag should be able to transform readily these cells that have low levels of IGF-IR, but where IRS-1 can still be tyrosyl phosphorylated by IGF-I or serum. We generated from R12 and R508 cells clones and mixed populations expressing The cells used were R-/T (R-T) and R-cells. Western blots with an antibody to IRS-1 (upper row) or to serine 616 (pS616) of IRS-1 (lower row). Growth conditions, serum-free medium (À) or 10% serum (FBS) are indicated below the lanes. Treatment of the lysates with alkaline phosphatase (AP) is indicated with þ . The upper row blot was done on a 7.5% gel, the lower blot on a regular 4-15% gel.
IRS-1 and T antigen T DeAngelis et al the temperature sensitive (ts) Tag (see Materials and methods). Transformation was measured by the usual method of colony formation in soft agar in 10% serum, with or without the supplementation with IGF-I. Figure 2 , panel a, confirms that R12 and R508 cells form very few colonies in soft agar. Expression of Tag, shown in Figure 2 , panel b, significantly increases the ability of these cells to form colonies in soft agar. The parental cell lines are negative for Tag, which is well expressed in the transfected cells. Certain clones are highly transformed, but all clones and mixed populations showed a significant increase in the ability to form colonies in soft agar over the parental cell lines. Figure 2 , panel c, confirms that in these cells, IGF-1 causes substantial tyrosyl phosphorylation of IRS-1, regardless of the presence or absence of Tag. This is significant, because it suggests that even very low levels of IGF-IR expression (too low for IGF-I-induced mitogenesis) are sufficient to allow Tag transformation of MEFs, provided that IRS-1 can be phosphorylated on tyrosines.
Insulin induces tyrosine phosphorylation of IRS-1 and promotes the growth of R-/T cells in soft agar If tyrosine phosphorylation of IRS-1 is critical for Tag transformation, R-/T cells would transform if we could find a way to phosphorylate IRS-1 on tyrosines. IGF-II and insulin activate the insulin receptor and promote growth of cells through the A isoform of this receptor Sciacca et al., 1999) . R-cells express the A isoform of the IR . We We then tested the ability of R-/T cells to form colonies in soft agar, when the medium was supplemented with the growth factors that increased tyrosine phosphorylation of IRS-1. The assay we used is very stringent, as we seed only 2000 cells/well and count only the colonies larger than 125 mm. The stringency of our criteria is shown by the fact that the positive controls, p6 cells (Pietrzkowski et al., 1992) , which have high levels of IGF-IR and are tumorigenic in mice, form colonies in soft agar only with a 20% efficiency.The results of separate experiments are summarized in Figure 3 , panel b, where the actual number of colonies is given. R-cells do not form colonies in soft agar, and R-/T cells, under these conditions, form a few small colonies (negative controls). Addition of IGF-I causes a slight but reproducible increase in the number of colonies generated by R-/T cells (in two experiments, from a total of six to a total of 22 colonies). However, addition of insulin (2 mg/ml) increases the number of total colonies (all three experiments) from 13 to 178, a significant increase. IGF-II also increased the number of colonies in soft agar (from six to 30), but it was not as effective as insulin. The higher effectiveness of insulin is reasonable as all growth factors in these cells stimulate through the IR, and insulin obviously has the highest affinity for the receptor.
The experiments of Figure 3 indicate that a modest tyrosyl phosphorylation of IRS-1 by growth factors increases the ability of R-/T cells to form colonies in soft agar, even in the absence of the IGF-IR. The number of colonies does not match the number of colonies produced by cells (like p6 cells) expressing high levels of IGF-IR, but the tyrosine phosphorylation of IRS-1 by insulin in R-cells is also very modest, in comparison to that in BalbA58 cells stimulated by IGF-1.
T antigen requires IRS-1 for survival and growth of 32D-derived myeloid cells To confirm a role of IRS-1 signaling in Tag transformation, we carried out experiments in 32D cells that do not express IRS-1 or IRS-2 (Wang et al., 1993; Valentinis et al., 1999) . In 32D cells, parental or derived, transformation is measured by the acquisition of IL-3 independence . 32D cells expressing only T antigen or only IRS-1 or both have been described previously by Zhou-li et al. (1997) and Prisco et al. (2002) , where the expression of T antigen or of IRS-1 was amply documented. Figure 4 shows growth and survival of 32D-derived cells after shifting from IL-3 to IGF-I. Panel a shows cell number after 24 h, and panel b after 48 h. We confirm our previous observation that Tag cannot protect 32D cells from apoptosis induced by IL-3 withdrawal, while ectopic expression of IRS-1 delays but does not prevent apoptosis (Zamorano et al., 1996; Zhou-li et al., 1997) . The combination of T antigen and IRS-1 allows survival of the cells, which actually grow in medium without IL-3 and supplemented with IGF-I. Like all 32D-derived cells, the 32D-derived cells of Figure 4 grow vigorously in IL-3 and die rapidly in medium without IL-3 and not supplemented with IGF-1 (data not shown, but see for instance Peruzzi et al., 1999) . This experiment indicates that IRS-1 and Tag, by themselves, cannot transform 32D cells, but can do so in combination. It also suggests that IRS-1 is a critical component, because Tag cannot transform 32D cells with the IGF-IR, but without IRS-1. . Lysates were immunoprecipitated with an antibody to IRS-1 and the Western blots were developed with an antibody to phosphotyrosine. BalbA58 cells were stimulated with the growth factors either from serum-free medium (SFM) or from 1% serum. BalbA58 were essentially used to monitor phosphorylation levels of IRS-1. Insulin, and to a lesser extent, the IGFs increase IRS-1 phosphorylation in R-/T cells, but to much lower levels than in BalbA58 cells. (b). Colony formation in soft agar was assayed as described in Materials and methods. The number of colonies refers to colonies larger than 125 mm after 3 weeks. We give the detailed results of the experiments, to indicate also the extent of variability of the soft agar assay as used in our laboratory. p6 are 3T3 cells expressing high levels of human IGF-IR (Pietrzkowski et al., 1992) .
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32D cells expressing a mutant IRS-1 are not transformed by T antigen
If an activated IRS-1 (which is known to increase PI3K activity) is a sine qua non for transformation by Tag, we reasoned that a mutant IRS-1 with key mutations at the PI3K-binding sites (tyrosines replaced by alanines) should fail to transform Tag-expressing 32D cells. The mutant IRS-1 we used, first described by Yenush et al. (1998) , was generated in our laboratory, and was described by Reiss et al. (2001) . It has three point mutations, at tyrosines 608, 939 and 895 (the numbers refer to mouse IRS-1, which is the one we mutated). The first two tyrosines bind the p85 subunit of PI3K (Sun et al., 1997) , while the third one binds Grb2 (growth factor-binding protein 2). This mutant IRS-1 is essentially inactive (Yenush et al., 1996 (Yenush et al., , 1998 Reiss et al., 2001) , although an IRS-1 with a single mutation at the Grb2-binding site is fully active . The mutant IRS-1 was introduced and expressed in 32D/T cells as shown in Figure 5 , inset (the expression of wildtype IRS-1 in 32D cells has been previously documented, see above). The cells were tested for growth in IGF-1, in the absence of IL-3. The results are shown in Figure 5 . Again, 32D/T-cells expressing wild-type IRS-1 grow in IL-3-independent fashion, but 32D/T cells expressing the mutant IRS-1 do not. They do slightly better than 32D/T cells, but by 72 h they are also dying off.
R-/T cells are transformed by a constitutively activated p110 subunit of PI3-K IRS-1 is known to be a powerful activator of the PI3K pathway (Myers et al., 1994; White, 1998) . On the basis of the experiments with the mutated IRS-1 protein, we hypothesized that the requirement of an active IRS-1 for transformation by T antigen could be mediated by PI3K. To test this hypothesis, we stably transfected into R-/T cells a constitutively activated p110 catalytic subunit of PI3K (Klippel et al., 1998) . Figure 6 , panel a shows that the p110 subunit is well expressed in transfected R-/T cells, while it is not detectable (by HA antibody) in the control, nontransfected cells. Panel b shows that in these cells Akt is constitutively phosphorylated. The phosphorylation is inhibited by LY 490029, an inhibitor of PI3K. Panel c shows the soft agar assays for R12, R12/T, R-/T and R-/T/p110 cells. R12 cells cannot form colonies in soft agar (it was actually 0), R-/T form a few small colonies (a total of seven in three plates). R-/T/p110 form many colonies (66 in three plates), some of which were exceedingly large. The R-/T/p110 cells form almost as many colonies as R12/T cells that have a tyrosyl-phosphorylated IRS-1. Treatment of R-/T/p110 cells with rapamycin, an inhibitor of p70 downstream of PI3K, inhibited colony formation (not shown). These results are compatible with our hypothesis that the effect of 
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UBF1 phosphorylation and ribosomal RNA synthesis in R-derived cells Nuclear IRS-1 binds to UBF1 (Tu et al., 2002; Sun et al., 2003) which must be phosphorylated to be activated (Voit et al., 1992 (Voit et al., , 1995 . The C-terminus is critical for the activation of UBF1 (Voit et al., 1992) and we have previously shown that the UBF1 C-terminus is phosphorylated by IGF-1 stimulation (Drakas et al., 2004) . We asked whether there was a difference in UBF1 phosphorylation between cells with a tyrosyl-phosphorylated IRS-1 (BalbA58 cells) and cells with a serine-phosphorylated IRS-1 (R-/T cells). First we confirmed that immunoprecipitation of nuclear lysates of R-/T cells with an antibody to IRS-1 shows interaction with UBF1 ( Figure 7, panel a) .The interaction is negative with lysates of R-/v-src cells, although IRS-1 is nuclear also in these cells (unpublished data from our laboratory). However, the levels of UBF are very low in R-/v-src cells (see Western blot), which, perhaps not coincidentally, are very small cells. We tested the phosphorylation of UBF1 in R-/T cells and in BalbA58 cells (Figure 7, panel b) . Phosphorylation of UBF1 in R-/T cells is low and does not change when the cells are stimulated by IGF-1. In BalbA58 cells, UBF1 phosphorylation is also low in unstimulated cells (albeit slightly higher than in R-/T cells), but increases sharply when the cells are stimulated with IGF-1. Panel c shows that there are no significant differences in UBF levels between the two cell lines.
If there are differences in UBF1 phosphorylation, there should be differences also in the levels of ribosomal RNA (rRNA) synthesis, which depends in part on the activation of UBF1 (Grummt, 1999) . This is The cell lines indicated above the lanes were serum starved, then stimulated with IGF-I (50 ng/ml). After 4 h, the cells were labeled for an additional 4 h with 32 P orthophosphate (see Materials and methods). Northern blots were autoradiographed, and the amount of RNA in each lane monitored by ethidium bromide staining of total RNA (not shown).
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indeed the case (Figure 7, panel d) . R-/T and other Rderived cells were labeled with 32 P orthophosphate (see Materials and methods), and rRNA synthesis visualized by autoradiography of Northern blots. The precursor rRNA and the two main forms are clearly visible in some lanes. There is a slight increase in rRNA synthesis in R-/T cells in respect to R-cells, but cells with an IGF-IR (and tyrosyl-phosphorylated IRS-1) have a more active rRNA synthesis, especially after stimulation with IGF-I. The purpose of these last experiments was to show that, while tyrosine phosphorylation of IRS-1 obviously depends on the activation of the IGF-IR, rRNA synthesis increase requires an active IRS-1. In R-/ T cells, with a serine-phosphorylated IRS-1, rRNA synthesis is much lower. (Castles et al., 1993) . Figure 8 , panel b shows that parental BT20 cells do not form colonies in soft agar larger than 125 mm, although they form small colonies, o125 mm in diameter. If our hypothesis on the role of IRS-1 in Tag transformation is correct, introduction of Tag in BT20 cells should fail to change their phenotype. This is shown in Figure 9 , panel b, where we present only our data with a mixed population of BT20-cells 
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expressing Tag. We also tested individual clones, with exactly the same results (data not shown). The expression of Tag ( Figure 9 , panel a) in BT20 cells fails to increase the number and size of colonies in soft agar ( Figure 9 , panel b). Ectopic expression of IRS-1 in BT20 cells causes transformation, as measured by colony formation in soft agar. Coexpression of Tag increases further the number of colonies in 10% serum, but not in IGF-1-supplemented medium. We then investigated the effect of IRS-1 on colony formation in soft agar of the H19-7 cell line and its derivatives. H19-7 cells are rat hippocampal cells that express the SV40 T antigen (Eves et al., 1992) . They have low levels of IGF-IR and IRS-1 . We tested the parental H19-7 cells and the H19-7/ IRS1/IGF-IR cells, which overexpress IRS-1 . In these cells, in medium not supplemented with IGF-I, IRS-1 is serine phosphorylated . Stimulation with IGF-I, however, causes IRS-1 to be tyrosine phosphorylated . When these cells are incubated in a soft agar assay, the results (Figure 9 , panel c) show that only H19-7/IRS-1/IGF-IR cells form a significant number of colonies in soft agar. The colony formation is especially dramatic when the medium is supplemented with IGF-I. Parental H19-7 cells, with low levels of IRS-1 and IGF-IR, do not form colonies in soft agar. These findings confirm that Tag is ineffective in cells not expressing IRS-1 or with serine-phosphorylated IRS-1.
Taken together, our experiments, summarized in Table 1 , confirm that an impairment of IRS-1 tyrosine phosphorylation (absence or low levels of IRS-1, or serine phosphorylation) severely compromises the ability of Tag to transform cells in culture (colony formation in soft agar or IL-3 independence).
Discussion
Our experiments provide a mechanism to explain the failure of Tag to transform MEFs that do not express the IGF-IR (Sell et al., 1993 (Sell et al., , 1994 . The evidence indicates that transformation by Tag requires tyrosine phosphorylation of IRS-1 and activation of the PI3K pathway. The evidence can be summarized as follows: (1) Tag fails to transform cells where IRS-1 is not expressed (32D cells and BT20 cells) , or is serine phosphorylated (R-/T cells, H19-7 cells) or is inactive (R-cells and 32DT cells expressing a mutant IRS-1). (2) Supraphysiological concentrations of insulin that cause a modest tyrosyl phosphorylation of IRS-1 in R-/T cells induce a significant and reproducible increase in colony formation in soft agar. (3) In MEFs expressing IRS-1, low levels of IGF-IR are sufficient to induce tyrosyl phosphorylation of IRS-1 and transformation by Tag. (4) PI3K activity is known to be markedly increased by IRS-1 and a constitutively activated p110 subunit of PI3K that bypasses the serine-phosphorylated IRS-1 transforms R-/T cells. These data have been summarized for convenience in Table 1 . There are 11 cell lines and/or conditions, in all of which Tag is expressed. In the six conditions where IRS-1 is tyrosyl phosphorylated, Tag is transforming. In the five conditions where IRS-1 is either absent or serine phosphorylated or otherwise inactive, T antigen does not transform. Taken together, these results and our previous data show that, in the cell lines tested, signaling from the IGF-IR and tyrosine phosphorylation of IRS-1 play a major role in transformation by Tag. By no means should these results be interpreted as indicating that IRS-1 is the only, or even the most important cofactor needed for T-antigen-induced transformation. The interactions of Tag with tumor suppressors like p53 and pRb are well documented, and well documented is their importance (Fanning, 1992; Ali and DeCaprio, 2001; Pipas and Levine, 2001) . These experiments simply show that the IGF-IR/IRS-1/PI3K pathway should be included in the list of mechanisms playing a role in the transforming ability of Tag. We will consider the above points separately.
A role of the IGF-IR in transformation by Tag was demonstrated by the report by Sell et al. (1993) that Transformation is based on the ability of forming colonies in soft agar or, in the case of 32D-derived cells, ability to grow in the absence of IL-3. The + sign indicates with insulin. R-/T do not form colonies in soft agar, but they do so when supplemented with insulin (modest but significant number of colonies).
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MEFs lacking the IGF-IR could not be transformed by Tag. In fact, these MEFs, called R-cells, are refractory to transformation by a number of cellular and viral oncogenes (Baserga, 2000) , with two exceptions, v-src and G a13 (Liu et al., 1997) . Zhou-li et al. (1995) subsequently showed that IRS-1 and Tag co-immunoprecipitated and that Tag could not transform (IL-3-independence) 32D myeloid cells (Zhou-li et al., 1997) , which do not express IRS-1 (see above). We show here that Tag cannot transform cells that do not express IRS-1 (32D or BT20 cells) or express very low levels (H19-7 cells). This is in agreement with a previous report that expression of an antisense RNA to IRS-1-inhibited Tag transformation of Balb/c 3T3 cells .
Lack of expression of IRS-1 is not unique to 32D or BT20 cells. There are several cell types that do not express IRS-1 and others that express very low levels (Sun et al., 1997) . It has been proposed that cells with low levels of IRS-1 (or no IRS-1 at all) are cells prone to differentiation (Baserga, 2004) . This is compatible with the finding that, in 32D cells, IRS-1 expression inhibits the differentiation induced by IGF-IR activation . The availability of other cell lines with low levels of or with absent IRS-1 make it easy to test our finding that the IGF-IR/IRS-1 combination is important in Tag transformation.
When MEFs express low levels of IGF-IR (R12 and R508 cells), they can readily be transformed by Tag (Figure 2 ). These cells have normal levels of IRS-1, which is tyrosyl phosphorylated by addition of IGF-1 (Figure 2c ). This gave us a clue in trying to identify the mechanism(s) underlying the relationship between the IGF-IR and transformation by Tag. R-cells, not having the IGF-IR, do not respond to IGF-1 with tyrosyl phosphorylation of IRS-1 (Rubini et al., 1997) and R-/T cells have a seryl phosphorylated IRS-1 (this paper). R12 cells, although having only 7 Â 10 3 IGF-IR/cell, phosphorylate IRS-1 on tyrosines (Reiss et al., 1998 and this paper) and are transformed by Tag (this paper). This is despite the fact that R12 cells do not respond to IGF-1 with DNA synthesis and only make an ineffectual response that stops before entrance into S phase (Reiss et al., 1998) . The activation of IRS-1 in these cells is sufficient to re-establish the full transforming activity of Tag.
The data of Figure 1 confirm that IRS-1 is seryl phosphorylated in R-/T cells. The control (R-/v-scr) shows that the methodology was correct. It is actually intriguing that v-src is one of two oncogenes that transform R-cells , and it tyrosyl phosphorylates IRS-1 quite strongly (Peterson et al., 1994) . We tried to induce tyrosyl phosphorylation of IRS-1 in R-/T cells, by using supraphysiological concentrations of insulin and IGF-II. For some reasons we cannot explain, IGF-II was not very effective in these cells, but insulin was. It induces tyrosyl phosphorylation of IRS-1 and colony formation in soft agar of R-/T cells. Actually, both IGF-II and IGF-I that interact weakly with the insulin receptor increase modestly the tyrosyl phosphorylation of IRS-1 and the number of colonies in soft agar. Their effect, however, is much less convincing than the effect of insulin. Insulin in serum is present at very low concentrations (picomolar) and the concentrations used in our experiments are supraphysiological (micromolar). However, its present effect cannot be mediated through the IGF-IR , which is absent in R-/T cells.
IRS-1 is a strong activator of PI3K (Myers et al., 1994; White, 1998) and we show here that a mutant IRS-1, where three key tyrosines have been replaced by point mutations, fails to rescue 32D/T cells from apoptosis while the wild type can. Using the insulin receptor as the signaling receptor, Yenush et al. (1998) showed that this mutant could not sustain DNA synthesis in 32D-derived cells, had no PI3K and p70 activity and had impaired Akt phosphorylation. This is not surprising, as two of the tyrosines mutated are the binding sites for PI3K . Our own mutant was tested in several experiments and it has no PI3K activity; it cannot induce Id protein expression and cannot sustain the growth of 32D-derived cells (Belletti et al., 2001; Reiss et al., 2001; Valentinis and Baserga, 2001 and this paper). The importance of the IRS-1/PI3K connection is confirmed by the results with the constitutively activated p110 subunit of PI3K that, bypassing IRS-1, allows T antigen to transform R-/T cells. Most of the experiments in this paper have been using a plasmid that expresses only the large T antigen of SV40 (Valentinis et al., 1994) thus ruling out a participation of small t in the IGF-1-mediated transformation by Tag.
Taken together, our results provide convincing evidence that, in the cell lines we used, an activated IGF-IR, and a tyrosyl-phoshorylated IRS-1 are a requirement for transformation by Tag. As to a possible secondary mechanism by which tyrosyl-phosphorylated IRS-1 may cooperate with Tag in transforming cells, IRS-1 binds to and activates UBF1, a key regulator of RNA polymerase I activity and therefore of rRNA synthesis (Voit et al., 1992; Drakas et al., 2004) . Tag also activates rRNA synthesis (Soprano et al., 1979 (Soprano et al., , 1983 Zhai et al., 1997) . However, according to Zhai et al. (1997) , T antigen binds to SL1, another protein that regulates the activity of the rDNA promoter (Grummt, 1999) . Since IRS-1 binds to UBF1, it raises the interesting hypothesis that for increased rDNA transcription (and possibly for transformation), Tag and IRS-1 cooperate, either for reciprocal activation or full rDNA transcription. The importance of rRNA synthesis in cell proliferation goes back to the pioneer work of Lieberman et al. (1963) . Recent reviews have summarized the evidence that rRNA synthesis and ribosome biogenesis may have a crucial role in transformation of cells (Grummt, 1999 , White, 2004 . Our results could provide one mechanism bridging transformation and rRNA synthesis.
While IGF-IR signaling may be added to the number of mechanisms that modulate the oncogenicity of Tag, there is a fundamental difference between the interactions of Tag with p53 or pRb on one side and IRS-1 on the other. In the case of p53 and pRb, a reasonable interpretation is that Tag, by binding to them, removes or neutralizes tumor suppressor gene products (Pipas and Levine, 2001 ). In the case of IRS-1, it seems more like a co-operation, as the IRS-1 pathway itself sends a strong mitogenic signal. In conclusion, we have provided evidence in several cell lines that the SV40 T antigen loses its ability to transform cells that do not express an IRS-1 that can be tyrosyl phosphorylated (Table 1) . This finding provides in turn a mechanism to explain the failure of Tag to transform MEFs that do not express the IGF-IR (Sell et al., 1993) . The fact that IRS-1 is translocated to the nuclei in Tag-expressing cells Prisco et al., 2002; Tu et al., 2002) is in itself an indication that Tag may find in IRS-1 a useful companion.
Materials and methods
Cell lines R-cells are MEFs derived from embryos with a targeted disruption of the IGF-IR genes (Sell et al., 1993) . R-/T cells are R-cells expressing the SV40 Tag (Sell et al., 1993) that do not grow in IGF-I and do not form colonies in soft agar. R12 and R508 cells are R-cells stably transfected with a plasmid expressing the human IGF-IR cDNA (Rubini et al., 1997) . Their receptor levels and their response to IGF-1 are described in Results. BalbA58 cells are Balb/c 3T3 cells (normal levels of IGF-IRs) transformed by a ts mutant of the SV40 Tag (Valentinis et al., 1994) . 32D and 32D-derived cells have been described by Zhou-li et al. (1997) and by Valentinis et al. (2000) . MCF-7 and other breast cancer cell lines (a kind gift of Dr Ewa Surmacz, Kimmel Cancer Center) were grown routinely in 10% serum.
New cell lines R12 and R508 cells were transfected with vectors ptsA58H, expressing the ts58 mutant of the SV40 Tag (Sell et al., 1994) , and pBSpac, expressing the puromycin resistance gene, using the FuGENE transfection reagent (Roche Molecular Biochemical, Indianapolis, IN, USA). Mixed populations or clones were selected with 2.5 mg/ml of puromycin. 32D/T/ IRS-1/PI3k-cells were obtained by transfection of 32D/T cells with a mutant IRS-1, having three point mutations at the binding sites for PI3-K and Grb2 . BT20 cells expressing the SV40 T antigen were generated also by transfection of the parental cells with ptsA58H and the puromycin resistance gene. BT20 cells expressing IRS-1 were generated by transfection with a plasmid expressing IRS-1 .
Growth curves
Exponentially growing 32D and 32D-derived cells were washed three times with HBSS and seeded 5 Â 10 4 /ml in IL-3-free medium (RPMI-1640 medium containing 10% heatinactivated FBS) supplemented with 10 nM IGF-I (GIBCO BRL), or 10% WEHI cell-conditioned medium as a source of IL-3. Cells were counted by standard procedures. Statistical analysis was carried out as previously described .
Colony formation in soft agar
The methodology previously described was followed (Sell et al., 1993) . Briefly, to compare anchorage-independent growth of different cell lines, cells were plated at 2 Â 10 3 in EMEM containing 10% FBS and 0.2% agarose (with 0.4% agarose underlay). The number of colonies larger than 125 mm in diameter was determined at 3 weeks following plating. Cells expressing the ts mutant of the SV40 Tag were assayed at 341C, all other cells at 371C.
Western blots
For Western blots and immunoprecipitation, we followed the same procedure described in previous papers from our laboratory Tu et al., 2002; Sun et al., 2003) . The antibodies used are indicated below.
p110 plasmid
This plasmid was a kind gift of Dr Marcus Thelen (TheodorKocher-Institut, University of Bern, Switzerland). It expresses a constitutively active p110 subunit of PI3K (Klippel et al., 1998) , p110CAAX (PLHACAAX), is HA-tagged and carries the gene for resistance to G418.
Phosphorylation of UBF1
The cells were labeled for 5 h with [ 32 P]orthophosphate at a final concentration of 1 mCi/ml (ICN Biochemicals Inc., Cleveland, OH, USA) in phosphate-free medium (Life Technologies Inc.). After labeling, the cells were collected by RIPA buffer for whole cell lysates, immunoprecipitated with an antibody to UBF, followed by Western blotting. After running the SDS-PAGE and transfer to membranes, the membranes were autoradiographed at À801C for 24 h. This technique is essentially the same as the one described by Grummt and co-workers (Voit et al., 1992) for UBF1 phosphorylation.
rRNA synthesis R þ , R-/T and R-cells were seeded at a density of 5 Â 10 4 cells/ ml in growth medium and eventually transferred to SFM for 48 h. The cells were stimulated with 50 ng/ml of IGF-I for 4 h. The cells were then labeled for 4 h with [ 32 P]orthophosphate at a final concentration of 250 mCi/ml (ICN Biochemicals Inc., Cleveland, OH, USA) in phosphate-free medium (Life Technologies, Inc.). Total RNA was isolated using RNeasy MiniKit (Qiagen) and separated by electrophoresis on 1% agarose formaldehyde gels. After drying, the 32 P-labeled rRNA was visualized by autoradiography.
Antibodies
Primary antibodies: polyclonal IRS-1 (Upstate Cell Signaling Solutions, Lake Placid, NY, USA); IRS-1 (pS616), polyclonal (Biosource International, Camarillo, CA, USA); PY20-HRPO, monoclonal (Transduction Laboratories); UBF1 (Santa Cruz) polyclonal; SV40 T antigen, monoclonal (Santa Cruz Biotechnology, Santa Cruz, CA, USA); HA.11 monoclonal antibody (Covance Research Products, Berkeley, CA, USA). Secondary antibodies: peroxidase goat anti-mouse IgG and peroxidase goat anti-rabbit IgG, both from Oncogene Research Products (San Diego, CA, USA); donkey anti-rabbit IgG-rhodamine and goat anti-mouse IgG-FITC, from Santa Cruz Biotechnology.
